$BLGO SEC Filings

Filed On	Filing
19 Oct 2026	Proxy statement: annual meeting on December 1, 2026 CEO pay $318K, down 0.1% · say-on-pay vote
02 Oct 2026	Form 4: Code Kenneth Reay, Director Received 566,261 shares as a grant or award ($45.3K) · Gave 2,000,000 shares as a gift
02 Oct 2026	Form 4: Calvert Dennis P, Director Received 931,886 shares as a grant or award ($74.6K) · Acquired 2,000,000 shares (Gift)
02 Oct 2026	Form 4: Marshall Dennis E, Director Granted 515,623 Option to Purchase Common Stock
02 Oct 2026	Form 4: Strommen Jack B., Director Granted 187,500 Option to Purchase Common Stock
02 Oct 2026	Form 4: Bray Christina Elaine, Director Granted 234,375 Option to Purchase Common Stock
02 Oct 2026	Form 4: Park Linda, Director Granted 234,375 Option to Purchase Common Stock
14 Sep 2026	8-K/A: Regulation FD Disclosure Dennis Calvert - President and Chief Executive Officer, BioLargo, Inc.
11 Sep 2026	8-K: Regulation FD Disclosure BioLargo, Inc. presented the slides attached as Exhibit 99.1, which are incorporated herein by reference, on September 10, 2026, at 1:00 PM Pacific Time, at a webcast investor conference.
14 Aug 2026	FORM 10-Q
07 Jul 2026	Form 4: Code Kenneth Reay, Director Received 532,567 shares as a grant or award ($60.4K)
02 Jul 2026	Form 4: Calvert Dennis P, Director Received 699,569 shares as a grant or award ($79.4K) · Received 219,914 shares as a grant or award ($24.9K)
02 Jul 2026	Form 4: Strommen Jack B., Director Granted 132,159 Option to Purchase Common Stock
02 Jul 2026	Form 4: Park Linda, Director Granted 165,198 Option to Purchase Common Stock
02 Jul 2026	Form 4: Bray Christina Elaine, Director Granted 165,198 Option to Purchase Common Stock
02 Jul 2026	Form 4: Marshall Dennis E, Director Granted 313,979 Option to Purchase Common Stock
24 Jun 2026	Form 4: Marshall Dennis E, Director Granted 40,909 Option to Purchase Common Stock
15 May 2026	FORM 10-Q
06 May 2026	8-K: Regulation FD Disclosure
04 May 2026	8-K: Regulation FD Disclosure

Comments